LLY FY2025 SEC EDGAR DEF 14A #6 of 168 in industry

ELI LILLY & Co CEO pay ratio

The CEO earned $36.7M in FY2025 against median worker pay of $125,100 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
IN
Filing date
2026-03-20
Industry
Chemicals & Pharmaceuticals
Industry rank
#6/168

Data updated August 2026

Subscribe to ELI LILLY & Co CEO pay filing updates (RSS)

CEO-to-worker pay ratio
293:1
High (Scale: 0–1000:1)
CEO pay
$36.7M
Median worker
$125,100

Answer first

ELI LILLY & Co's FY2025 CEO total of $36.7M ranks #43 of 1,423 complete filings; its 293:1 pay ratio ranks #195. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $125,100. Industry placement uses the FY2025 SIC-28 peer cohort (# 6 of 168, 97th percentile - top 5% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#43
$36.7M of 1,423 FY2025
Ratio rank
#195
293:1 of 1,423
Industry pct
97th
top 5% of industry peers by pay ratio

How ELI LILLY & Co ranks nationally

ELI LILLY & Co CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$36,698,337 Top 3% higher than 97% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). Below this entry. $22,500,000–$25,000,000: 34 companies (2%). Below this entry. $25,000,000–$27,500,000: 24 companies (2%). Below this entry. $27,500,000–$30,000,000: 16 companies (1%). Below this entry. $30,000,000–$32,500,000: 10 companies (1%). Below this entry. $32,500,000–$35,000,000: 7 companies (0%). Below this entry. $35,000,000–$37,500,000: 9 companies (1%). This entry sits in this band. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

ELI LILLY & Co vs. Chemicals & Pharmaceuticals peers

CEO total pay ($36.7M) against pay ratio (293:1) for ELI LILLY & Co (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6132911.514138142.022143372.530148603.038153833.527.8:1106.1:1184.5:1262.9:1341.3:1CEO total payPay ratio (CEO : median worker)ELI LILLY & Co, CEO total pay: 36698337 · Pay ratio (CEO : median worker): 293:1ELI LILLY & CoPfizer Inc, CEO total pay: 27585301 · Pay ratio (CEO : median worker): 277:1Pfizer IncHarrow, Inc., CEO total pay: 23606274 · Pay ratio (CEO : median worker): 263:1Harrow, Inc.Viatris Inc, CEO total pay: 15280383 · Pay ratio (CEO : median worker): 327:1Viatris IncTeva Pharmaceutical Industries Ltd, CEO total pay: 19168709 · Pay ratio (CEO : median worker): 257:1Teva Pharmaceutical Industries LtdTrulieve Cannabis Corp., CEO total pay: 7588408 · Pay ratio (CEO : median worker): 243:1Trulieve Cannabis Corp.
ELI LILLY & Co vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in ELI LILLY & Co's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · ELI LILLY & Co

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
293:1
FY2025
vs prior FY
+50:1
from FY2024 243:1
CEO $ YoY
+25%
$36.7M latest
Filings shown
4
FY2022–2025
ELI LILLY & Co CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $21.4M - $124,103 172:1 -
2023 $26.6M +24% $157,937 168:1 -4:1
2024 $29.2M +10% $120,574 243:1 +75:1
2025 $36.7M +25% $125,100 293:1 +50:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 59478, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
293:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$36.7M
Companies in Industry
168
vs. Industry Median
Above
#6 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

ELI LILLY & Co: STEEP · PEAK pay ratio

ELI LILLY & Co's FY2025 ratio 293:1 ranks #6 of 168 Chemicals & Pharmaceuticals filers (97th percentile). the CEO earned 293× the median employee ($125,100) in FY2025.

Median employee $125,100 (ELITE-MED); STEEP · PEAK stamps put about 293 median-wage years per CEO year.

CEO Total Pay

$36.7M

FY2025 Summary Compensation, well above median

Pay Ratio

293:1

Elevated vs. peers

ELI LILLY & Co in the higher Chemicals & Pharmaceuticals third

ELI LILLY & Co's FY2025 ratio 293:1 ranks #6 of 168 Chemicals & Pharmaceuticals filers (97th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; ELI LILLY & Co's $36.7M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #43 and ratio rank #195 split - treat 293:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$36.7M
Median Employee Pay
$125,100
Pay Ratio
293:1
Filing Date
2026-03-20

Company Info

Ticker
LLY
CIK
59478
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
IN
View SEC filings →
SEC EDGAR DEF 14A for CIK 59478, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. ELI LILLY & Co's FY2025 ratio 293:1 ranks #6 of 168 Chemicals & Pharmaceuticals filers (97th percentile).

Read with ELI LILLY & Co

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · ELITE-MED.

American Electric Power Co Inc · PEAK

ABS(ceo_total_comp) peer at $36.6M (Δ $97K lighter vs ELI LILLY & Co); STEEP · ELITE-MED vs this page's STEEP · PEAK · ELITE-MED.
Costar Group, Inc. · PEAK

ABS(ceo_total_comp) peer at $36.4M (Δ $266K lighter vs ELI LILLY & Co); HIGH · ELITE-MED vs this page's STEEP · PEAK · ELITE-MED.
Nvidia Corp · PEAK

ABS(ceo_total_comp) peer at $36.4M (Δ $314K lighter vs ELI LILLY & Co); MID · ELITE-MED vs this page's STEEP · PEAK · ELITE-MED.
Nlight, Inc. · PEAK

ABS(ceo_total_comp) peer at $37.3M (Δ $618K heavier vs ELI LILLY & Co); HIGH · HIGH-MED vs this page's STEEP · PEAK · ELITE-MED.
Pfizer Inc (SIC 28 pole)

Pfizer Inc stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to ELI LILLY & Co's STEEP filing.
National dual ranks · #43/#195

ELI LILLY & Co's FY2025 package sits #43 by CEO dollars and #195 by ratio under PEAK · STEEP.
Comp structure · PEAK

ELI LILLY & Co's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for ELI LILLY & Co (CIK 59478), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.